Vinorelbine News and Research

RSS
Vinorelbine is an anticancer drug that belongs to the family of plant drugs called vinca alkaloids.
ADVENTRX Pharmaceuticals announces 6-month stability data for Exelbine

ADVENTRX Pharmaceuticals announces 6-month stability data for Exelbine

Study calls for optimized medical treatment for older patients with advanced lung cancer

Study calls for optimized medical treatment for older patients with advanced lung cancer

Investment report on ADVENTRX Pharmaceuticals

Investment report on ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals to meet FDA to review its NDA for ANX-530

ADVENTRX Pharmaceuticals to meet FDA to review its NDA for ANX-530

FDA accepts proposed proprietary name Exelbine for ADVENTRX Pharmaceuticals' ANX-530

FDA accepts proposed proprietary name Exelbine for ADVENTRX Pharmaceuticals' ANX-530

ADVENTRX' ANX-530 NDA: FDA issues refuse to file letter

ADVENTRX' ANX-530 NDA: FDA issues refuse to file letter

ADVENTRX Pharmaceuticals submits a NDA for its vinorelbine injectable emulsion

ADVENTRX Pharmaceuticals submits a NDA for its vinorelbine injectable emulsion

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Pfizer announces results from studies evaluating neratinib

Pfizer announces results from studies evaluating neratinib

Pfizer to present study findings from its expanded breast cancer portfolio

Pfizer to present study findings from its expanded breast cancer portfolio

Sagent announces launch of vinorelbine injection

Sagent announces launch of vinorelbine injection

Genentech announces Phase III study results for Avastin (bevacizumab) in combination with chemo in HER2-negative breast cancer

Genentech announces Phase III study results for Avastin (bevacizumab) in combination with chemo in HER2-negative breast cancer

ADVENTRX Pharmaceuticals announces closing of financing

ADVENTRX Pharmaceuticals announces closing of financing

Combining two chemotherapy drugs with Herceptin shows promise for metastatic HER2+ breast cancer

Combining two chemotherapy drugs with Herceptin shows promise for metastatic HER2+ breast cancer

Seattle Genetics presents new data on antibody-drug conjugate

Seattle Genetics presents new data on antibody-drug conjugate

Asbestos-induced lung cancer patients do not appear to benefit from chemotherapy

Asbestos-induced lung cancer patients do not appear to benefit from chemotherapy

BRCA1 gene plays significant role in non-small cell lung cancer

BRCA1 gene plays significant role in non-small cell lung cancer

Massive gene screening points way to more effective chemotherapy

Massive gene screening points way to more effective chemotherapy

Substance found in evening primrose oil inhibits breast cancer gene

Substance found in evening primrose oil inhibits breast cancer gene

Brief course of chemotherapy after surgery should be the new standard of care around the world

Brief course of chemotherapy after surgery should be the new standard of care around the world